Get startedLog in
    Picture of TriSalus Life Sciences logo

    TLSI — TriSalus Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    All News

    Brief: TriSalus Life Sciences Secures Up To $50 Mln Of Debt Financing With Orbimed

    Picture of TriSalus Life Sciences logoTriSalus Life Sciences
    30/04/2024 23:04
    April 30 (Reuters) - TriSalus Life Sciences Inc
 TLSI.O :
    * TRISALUS LIFE SCIENCES SECURES UP TO $50 MILLION OF DEBT
FINANCING WITH ORBIMED TO SUPPORT TRINAV® INFUSION SYSTEM GROWTH
INITIATIVES
    * TRISALUS LIFE SCIENCES: FULL FUNDING IN CREDIT AGREEMENT &
CURRENT CASH & CASH EQUIVALENTS ON HAND, TO EXTEND CO'S CASH
RUNWAY THROUGH 2025
    * TRISALUS LIFE SCIENCES INC: CAPITAL FROM TRANSACTION IS
EXPECTED
TO SUPPORT EXECUTION OF STRATEGIC EXPANSION AND FUEL CONTINUED
GROWTH

Source text for Eikon:  ID:nBw2Bh53va 
Further company coverage:  TLSI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on TriSalus Life Sciences

    See all news